Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.330 |
None |
1.000 |
3 |
|
2009 |
2019 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Brain Edema
|
phenotype |
Nervous System Diseases
|
Pathologic Function
|
30
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
1993 |
1993 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
15 |
|
2003 |
2020 |
Chronic Obstructive Airway Disease
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
1428
|
852
|
0.100 |
None |
0.667 |
12 |
5
|
2006 |
2019 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
4
|
2018 |
2018 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Platelet mean volume determination (procedure)
|
phenotype |
|
Laboratory Procedure
|
223
|
371
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Interleukin 2 Measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Stem Cell Factor Measurement
|
phenotype |
|
Laboratory Procedure
|
4
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Soluble Interleukin 6 Receptor Measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
25
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.080 |
None |
1.000 |
8 |
|
2003 |
2020 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.070 |
None |
1.000 |
7 |
|
2003 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2019 |
Pulmonary Emphysema
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
352
|
64
|
0.030 |
None |
1.000 |
3 |
3
|
2010 |
2015 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.030 |
None |
1.000 |
3 |
|
2008 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2019 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2020 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
979
|
287
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2002 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
1543
|
348
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2017 |